Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Aug 1;160(2):472–493. doi: 10.1084/jem.160.2.472

Molecular localization of human class II MT2 and MT3 determinants

PMCID: PMC2187460  PMID: 6206179

Abstract

The specificities of the monoclonal antibodies I-LR2 and 109d6, which recognize MT2- and MT3-like serologic determinants, respectively, have been confirmed by panel testing. In addition, the relationships of these antibodies to other monoclonal antibodies and alloantisera have been studied by means of cell surface fluorescence, complement- dependent cytotoxicity and immunoprecipitation. Using these monoclonal antibodies, molecules encoded by the HLA-D region have been isolated and characterized by amino acid sequencing and peptide mapping. By these criteria, the major populations of molecules bearing MT2- and MT3- like determinants are indistinguishable from DR molecules.

Full Text

The Full Text of this article is available as a PDF (1.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews D. W., Bono M. R., Strominger J. L. A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing. Biochemistry. 1982 Dec 21;21(26):6625–6628. doi: 10.1021/bi00269a002. [DOI] [PubMed] [Google Scholar]
  2. Auffray C., Lillie J. W., Arnot D., Grossberger D., Kappes D., Strominger J. L. Isotypic and allotypic variation of human class II histocompatibility antigen alpha-chain genes. Nature. 1984 Mar 22;308(5957):327–333. doi: 10.1038/308327a0. [DOI] [PubMed] [Google Scholar]
  3. Bach F. H., Watson A. J. Dw/LD associated molecular polymorphism of DR4 beta-chains: intramolecular localization of polymorphic sites. J Immunol. 1983 Oct;131(4):1622–1625. [PubMed] [Google Scholar]
  4. Ball E. J., Stastny P. Antigen-specific HLA-restricted human T-cell lines. I. An MT3-like restriction determinant distinct from HLA-DR. Immunogenetics. 1984;19(1):13–26. doi: 10.1007/BF00364472. [DOI] [PubMed] [Google Scholar]
  5. Berle E. J., Jr, Thorsby E. Both DR and MT class II HLA molecules may restrict proliferative T-lymphocyte responses to antigen. Scand J Immunol. 1982 Dec;16(6):543–547. doi: 10.1111/j.1365-3083.1982.tb00757.x. [DOI] [PubMed] [Google Scholar]
  6. Bono M. R., Strominger J. L. Direct evidence of homology between human DC-1 antigen and murine I-A molecules. Nature. 1982 Oct 28;299(5886):836–840. doi: 10.1038/299836a0. [DOI] [PubMed] [Google Scholar]
  7. Corte G., Calabi F., Damiani G., Bargellesi A., Tosi R., Sorrentino R. Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants. Nature. 1981 Jul 23;292(5821):357–360. doi: 10.1038/292357a0. [DOI] [PubMed] [Google Scholar]
  8. De Kretser T. A., Crumpton M. J., Bodmer J. G., Bodmer W. F. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus. Eur J Immunol. 1982 Jul;12(7):600–606. doi: 10.1002/eji.1830120713. [DOI] [PubMed] [Google Scholar]
  9. DeMars R., Chang C. C., Marrari M., Duquesnoy R. J., Noreen H., Segall M., Bach F. H. Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line. J Immunol. 1983 Sep;131(3):1318–1321. [PubMed] [Google Scholar]
  10. DeMars R., Chang C. C., Rudersdorf R. A. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line. Hum Immunol. 1983 Oct;8(2):123–139. doi: 10.1016/0198-8859(83)90008-3. [DOI] [PubMed] [Google Scholar]
  11. Duquesnoy R. J., Marrari M., Annen K. Identification of an HLA-DR-associated system of B-cell alloantigens. Transplant Proc. 1979 Dec;11(4):1757–1760. [PubMed] [Google Scholar]
  12. Finn O. J., Stackhouse C. J., Metzgar R. S. Human Ia beta chains and the invariant chain share a common antigenic determinant. J Exp Med. 1983 Oct 1;158(4):1344–1349. doi: 10.1084/jem.158.4.1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gibofsky A., Winchester R. J., Patarroyo M., Fotino M., Kunkel H. G. Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J Exp Med. 1978 Dec 1;148(6):1728–1732. doi: 10.1084/jem.148.6.1728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Giles R. C., Nunez G., Hurley C. K., Nunez-Roldan A., Winchester R., Stastny P., Capra J. D. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med. 1983 May 1;157(5):1461–1470. doi: 10.1084/jem.157.5.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goyert S. M., Moriuchi J., Winchester R., Silver J. HLA-DS molecules and their relation to supertypic specificities. Hum Immunol. 1983 Sep;8(1):53–63. doi: 10.1016/0198-8859(83)90082-4. [DOI] [PubMed] [Google Scholar]
  16. Goyert S. M., Shively J. E., Silver J. Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules. J Exp Med. 1982 Aug 1;156(2):550–566. doi: 10.1084/jem.156.2.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Goyert S. M., Silver J. Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5719–5723. doi: 10.1073/pnas.80.18.5719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hurley C. K., Nunez G., Winchester R., Finn O. J., Levy R., Capra J. D. The human HLA-DR antigens are encoded by multiple beta-chain loci. J Immunol. 1982 Nov;129(5):2103–2108. [PubMed] [Google Scholar]
  19. Hurley C. K., Shaw S., Nadler L., Schlossman S., Capra J. D. Alpha and beta chains of SB and DR antigens are structurally distinct. J Exp Med. 1982 Nov 1;156(5):1557–1562. doi: 10.1084/jem.156.5.1557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Karr R. W., Kannapell C. C., Stein J. A., Gebel H. M., Mann D. L., Duquesnoy R. J., Fuller T. C., Rodey G. E., Schwartz B. D. Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol. 1982 Apr;128(4):1809–1818. [PubMed] [Google Scholar]
  21. Karr R. W., Kannapell C. C., Zangara R. J., Goyert S. M., Silver J., Schwartz B. D. An HLA-DR5 homozygous cell line expresses two DS (I-A-like) molecules. J Exp Med. 1983 Oct 1;158(4):1374–1379. doi: 10.1084/jem.158.4.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Koning F., Schreuder I., Giphart M., Bruning H. A mouse monoclonal antibody detecting a DR-related MT2-like specificity: serology and biochemistry. Hum Immunol. 1984 Apr;9(4):221–230. doi: 10.1016/0198-8859(84)90027-2. [DOI] [PubMed] [Google Scholar]
  23. Kratzin H., Yang C. Y., Götz H., Pauly E., Kölbel S., Egert G., Thinnes F. P., Wernet P., Altevogt P., Hilschmann N. Primärstruktur menschlicher Histokompatibilitätsantigene der Klasse II. 1. Mitteilung: Aminosäuresequenz der N-terminalen 198 Reste der beta-Kette des HLA-Dw2,2;DR2,2-Alloantigens. Hoppe Seylers Z Physiol Chem. 1981 Dec;362(12):1665–1669. [PubMed] [Google Scholar]
  24. Ligler F., Vitetta E. S., Uhr J. W. Cell surface immunoglobulin. XXII. Reappearance of surface IgM and IgD on murine splenocytes after removal by capping. J Immunol. 1977 Oct;119(4):1545–1546. [PubMed] [Google Scholar]
  25. Maeda H., Hirata R. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines. J Immunol. 1984 Feb;132(2):574–577. [PubMed] [Google Scholar]
  26. Markert M. L., Cresswell P. Human B cell alloantigens: expression of MB and MT determinants. J Immunol. 1982 May;128(5):2004–2008. [PubMed] [Google Scholar]
  27. Markert M. L., Cresswell P. Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6101–6104. doi: 10.1073/pnas.77.10.6101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Moriuchi J., Katagiri M., Wakisaka A., Matsuura N., Maruyama N., Ikeda H., Aizawa M., Itakura K. Association of B cell alloantigen with juvenile onset diabetes mellitus in the Japanese. Hum Immunol. 1980 Dec;1(4):357–362. doi: 10.1016/0198-8859(80)90111-1. [DOI] [PubMed] [Google Scholar]
  29. Moutsopoulos H. M., Mann D. L., Johnson A. H., Chused T. M. Genetic differences between primary and secondary sicca syndrome. N Engl J Med. 1979 Oct 4;301(14):761–763. doi: 10.1056/NEJM197910043011405. [DOI] [PubMed] [Google Scholar]
  30. Nadler L. M., Stashenko P., Hardy R., Pesando J. M., Yunis E. J., Schlossman S. F. Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. Hum Immunol. 1981 Feb;2(1):77–90. doi: 10.1016/0198-8859(81)90009-4. [DOI] [PubMed] [Google Scholar]
  31. Nunez-Roldan A., Szer I., Toguchi T., Cuttner J., Winchester R. Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series. J Exp Med. 1982 Dec 1;156(6):1872–1877. doi: 10.1084/jem.156.6.1872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ohta N., Nishimura Y. K., Tanimoto K., Horiuchi Y., Abe C., Shiokawa Y., Abe T., Katagiri M., Yoshiki T., Sasazuki T. Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol. 1982 Oct;5(2):123–132. doi: 10.1016/0198-8859(82)90057-x. [DOI] [PubMed] [Google Scholar]
  33. Park M. S., Terasaki P. I., Bernoco D., Iwaki Y. Evidence for a second B-cell locus separate from the DR locus. Transplant Proc. 1978 Dec;10(4):823–828. [PubMed] [Google Scholar]
  34. Pierres M., Devaux C., Dosseto M., Marchetto S. Clonal analysis of B- and T-cell responses to Ia antigens. I. Topology of epitope regions on I-Ak and I-Ek molecules analyzed with 35 monoclonal alloantibodies. Immunogenetics. 1981 Dec;14(6):481–495. doi: 10.1007/BF00350120. [DOI] [PubMed] [Google Scholar]
  35. Pierres M., Mercier P., Madsen M., Mawas C., Kristensen T. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities. Tissue Antigens. 1982 Apr;19(4):289–300. doi: 10.1111/j.1399-0039.1982.tb01452.x. [DOI] [PubMed] [Google Scholar]
  36. Ploegh H. L., Orr H. T., Strominger J. L. Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules. Cell. 1981 May;24(2):287–299. doi: 10.1016/0092-8674(81)90318-4. [DOI] [PubMed] [Google Scholar]
  37. Radka S. F., Machamer C., Cresswell P., Kostyu D. D., Ward F. E., Amos D. B. SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity. J Immunol. 1983 Apr;130(4):1863–1866. [PubMed] [Google Scholar]
  38. Shackelford D. A., Kaufman J. F., Korman A. J., Strominger J. L. HLA-DR antigens: structure, separation of subpopulations, gene cloning and function. Immunol Rev. 1982;66:133–187. doi: 10.1111/j.1600-065x.1982.tb00437.x. [DOI] [PubMed] [Google Scholar]
  39. Shackelford D. A., Mann D. L., van Rood J. J., Ferrara G. B., Strominger J. L. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4566–4570. doi: 10.1073/pnas.78.7.4566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Shaw S., DeMars R., Schlossman S. F., Smith P. L., Lampson L. A., Nadler L. M. Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure. J Exp Med. 1982 Sep 1;156(3):731–743. doi: 10.1084/jem.156.3.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sorrentino R., Corte G., Calabi F., Tanigaki N., Tosi R. Microfingerprinting analysis of human Ia molecules favours a three loci model. Mol Immunol. 1983 Mar;20(3):333–343. doi: 10.1016/0161-5890(83)90073-1. [DOI] [PubMed] [Google Scholar]
  42. Stastny P., Ball E. J., Dry P. J., Nunez G. The human immune response region (HLA-D) and disease susceptibility. Immunol Rev. 1983;70:113–153. doi: 10.1111/j.1600-065x.1983.tb00712.x. [DOI] [PubMed] [Google Scholar]
  43. Tanigaki N., Tosi R., Duquesnoy R. J., Ferrara G. B. Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med. 1983 Jan 1;157(1):231–247. doi: 10.1084/jem.157.1.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tanigaki N., Tosi R., Sagawa K., Minowada J., Ferrara G. B. The distribution of DR5, MT2, and MB3 specificities on human Ia subsets. Immunogenetics. 1983;17(4):371–386. doi: 10.1007/BF00372456. [DOI] [PubMed] [Google Scholar]
  45. Tanigaki N., Tosi R. The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities. Immunol Rev. 1982;66:5–37. doi: 10.1111/j.1600-065x.1982.tb00432.x. [DOI] [PubMed] [Google Scholar]
  46. Taylor C. G., Grumet F. C. HLA-DR antigen grouping by use of monoclonal antibody probes: expansion of known groups, and mechanism of cytotoxicity blocking. J Immunol. 1982 Mar;128(3):1489–1490. [PubMed] [Google Scholar]
  47. Toguchi T., Burmester G., Nunez-Roldan A., Gregersen P., Seremetis S., Lee S., Szer I., Winchester R. Evidence for the separate molecular expression of four distinct polymorphic Ia epitopes on cells of DR4 homozygous individuals. Hum Immunol. 1984 Jun;10(2):69–81. doi: 10.1016/0198-8859(84)90074-0. [DOI] [PubMed] [Google Scholar]
  48. Ugolini V., Nunez G., Smith R. G., Stastny P., Capra J. D. Initial characterization of monoclonal antibodies against human monocytes. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6764–6768. doi: 10.1073/pnas.77.11.6764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Winchester R. J., Wernet P., Kunkel H. G., Dupont B., Jersild C., Fu S. M. Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med. 1975 Apr 1;141(4):924–929. [PMC free article] [PubMed] [Google Scholar]
  50. Winchester R., Toguchi T., Szer I., Burmester G., Lo Galbo P., Cuttner J., Capra J. D., Nunez-Roldan A. Association of susceptibility to certain hematopoietic malignancies with the presence of Ia allodeterminants distinct from the DR series; utility of monoclonal antibody reagents. Immunol Rev. 1983;70:155–166. doi: 10.1111/j.1600-065x.1983.tb00713.x. [DOI] [PubMed] [Google Scholar]
  51. Zeevi A., Annen K., Scheffel C., Duquesnoy R. J. Detection of non-HLA-DR determinants by alloreactive lymphocyte clones. Hum Immunol. 1983 Feb;6(2):97–109. doi: 10.1016/0198-8859(83)90066-6. [DOI] [PubMed] [Google Scholar]
  52. Zeevi A., Scheffel C., Annen K., Bass G., Marrari M., Duquesnoy R. J. Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants. Immunogenetics. 1982;16(3):209–218. doi: 10.1007/BF00343310. [DOI] [PubMed] [Google Scholar]
  53. van Rood J. J., van Leeuwen A., Termijtelen A., Keuning J. J. B-cell antibodies, Ia-like determinants, and their relation to MLC determinants in man. Transplant Rev. 1976;30:122–139. doi: 10.1111/j.1600-065x.1976.tb00218.x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES